

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine metabolic process (GO:0006553) | 6.49528176 |
| 2 | lysine catabolic process (GO:0006554) | 6.49528176 |
| 3 | drug transmembrane transport (GO:0006855) | 4.81134954 |
| 4 | urate metabolic process (GO:0046415) | 4.70975506 |
| 5 | cysteine metabolic process (GO:0006534) | 4.65813898 |
| 6 | 2-oxoglutarate metabolic process (GO:0006103) | 4.59156602 |
| 7 | valine metabolic process (GO:0006573) | 4.58919998 |
| 8 | surfactant homeostasis (GO:0043129) | 4.53316452 |
| 9 | aspartate family amino acid catabolic process (GO:0009068) | 4.39711921 |
| 10 | fatty acid beta-oxidation (GO:0006635) | 4.39600181 |
| 11 | glyoxylate metabolic process (GO:0046487) | 4.32729378 |
| 12 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 4.29207704 |
| 13 | fatty acid transmembrane transport (GO:1902001) | 4.24171703 |
| 14 | tricarboxylic acid metabolic process (GO:0072350) | 4.18285854 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.16113969 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 4.11536722 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.11536722 |
| 18 | fatty acid oxidation (GO:0019395) | 4.08312667 |
| 19 | acetyl-CoA metabolic process (GO:0006084) | 4.07181655 |
| 20 | quaternary ammonium group transport (GO:0015697) | 4.05639667 |
| 21 | short-chain fatty acid metabolic process (GO:0046459) | 4.03487174 |
| 22 | L-phenylalanine catabolic process (GO:0006559) | 4.00383410 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.00383410 |
| 24 | carnitine transport (GO:0015879) | 4.00227236 |
| 25 | amino-acid betaine transport (GO:0015838) | 4.00227236 |
| 26 | lipid oxidation (GO:0034440) | 3.99385236 |
| 27 | drug transport (GO:0015893) | 3.95306832 |
| 28 | low-density lipoprotein particle clearance (GO:0034383) | 3.95046821 |
| 29 | amino-acid betaine metabolic process (GO:0006577) | 3.83467314 |
| 30 | carnitine shuttle (GO:0006853) | 3.80035712 |
| 31 | homocysteine metabolic process (GO:0050667) | 3.76300206 |
| 32 | branched-chain amino acid metabolic process (GO:0009081) | 3.75837359 |
| 33 | fatty acid catabolic process (GO:0009062) | 3.75135973 |
| 34 | aromatic amino acid family catabolic process (GO:0009074) | 3.75018781 |
| 35 | carnitine metabolic process (GO:0009437) | 3.69555122 |
| 36 | * response to mercury ion (GO:0046689) | 3.66687482 |
| 37 | kynurenine metabolic process (GO:0070189) | 3.66532809 |
| 38 | biotin metabolic process (GO:0006768) | 3.62894460 |
| 39 | alpha-linolenic acid metabolic process (GO:0036109) | 3.62329181 |
| 40 | phosphate ion transport (GO:0006817) | 3.60622284 |
| 41 | tricarboxylic acid cycle (GO:0006099) | 3.58578683 |
| 42 | drug catabolic process (GO:0042737) | 3.55470321 |
| 43 | phosphate ion transmembrane transport (GO:0035435) | 3.55209478 |
| 44 | cellular ketone body metabolic process (GO:0046950) | 3.53645839 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 3.53642957 |
| 46 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.53039738 |
| 47 | indole-containing compound catabolic process (GO:0042436) | 3.51903680 |
| 48 | indolalkylamine catabolic process (GO:0046218) | 3.51903680 |
| 49 | tryptophan catabolic process (GO:0006569) | 3.51903680 |
| 50 | ethanol oxidation (GO:0006069) | 3.46693127 |
| 51 | carnitine transmembrane transport (GO:1902603) | 3.46014451 |
| 52 | chemical homeostasis within a tissue (GO:0048875) | 3.44724276 |
| 53 | branched-chain amino acid catabolic process (GO:0009083) | 3.41354419 |
| 54 | NADH metabolic process (GO:0006734) | 3.38397510 |
| 55 | monocarboxylic acid catabolic process (GO:0072329) | 3.35999158 |
| 56 | oxaloacetate metabolic process (GO:0006107) | 3.33374976 |
| 57 | tryptophan metabolic process (GO:0006568) | 3.30219173 |
| 58 | exogenous drug catabolic process (GO:0042738) | 3.30190670 |
| 59 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.28626581 |
| 60 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.28324529 |
| 61 | organic cation transport (GO:0015695) | 3.27684520 |
| 62 | regulation of sequestering of triglyceride (GO:0010889) | 3.26625965 |
| 63 | cGMP-mediated signaling (GO:0019934) | 3.20900381 |
| 64 | serine family amino acid catabolic process (GO:0009071) | 3.16993761 |
| 65 | transcytosis (GO:0045056) | 3.15444550 |
| 66 | sodium ion export (GO:0071436) | 3.15412389 |
| 67 | regulation of cholesterol storage (GO:0010885) | 3.12317570 |
| 68 | regulation of fatty acid oxidation (GO:0046320) | 3.11390074 |
| 69 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.07047733 |
| 70 | astrocyte differentiation (GO:0048708) | 3.06766465 |
| 71 | positive regulation of fatty acid oxidation (GO:0046321) | 3.03637284 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 3.01307578 |
| 73 | ketone body metabolic process (GO:1902224) | 3.00734695 |
| 74 | alpha-amino acid catabolic process (GO:1901606) | 2.98745023 |
| 75 | drug metabolic process (GO:0017144) | 2.97530481 |
| 76 | glutamate metabolic process (GO:0006536) | 2.94482008 |
| 77 | succinate metabolic process (GO:0006105) | 2.94282927 |
| 78 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.92813004 |
| 79 | carboxylic acid catabolic process (GO:0046395) | 2.92115720 |
| 80 | organic acid catabolic process (GO:0016054) | 2.92115720 |
| 81 | lymph vessel development (GO:0001945) | 2.92068204 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 2.91871075 |
| 83 | epoxygenase P450 pathway (GO:0019373) | 2.91595014 |
| 84 | regulation of endothelial cell differentiation (GO:0045601) | 2.91242833 |
| 85 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.90741573 |
| 86 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.89536335 |
| 87 | blood vessel maturation (GO:0001955) | 2.89121222 |
| 88 | cellular response to epinephrine stimulus (GO:0071872) | 2.88912630 |
| 89 | negative regulation of fibrinolysis (GO:0051918) | 2.88892211 |
| 90 | response to phenylpropanoid (GO:0080184) | 2.87944907 |
| 91 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.86428248 |
| 92 | axon ensheathment in central nervous system (GO:0032291) | 2.83944040 |
| 93 | central nervous system myelination (GO:0022010) | 2.83944040 |
| 94 | excretion (GO:0007588) | 2.83210824 |
| 95 | complement activation, alternative pathway (GO:0006957) | 2.83058002 |
| 96 | cellular potassium ion homeostasis (GO:0030007) | 2.82954474 |
| 97 | bile acid biosynthetic process (GO:0006699) | 2.82926136 |
| 98 | regulation of cholesterol homeostasis (GO:2000188) | 2.82174813 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 2.80862149 |
| 100 | negative regulation of catenin import into nucleus (GO:0035414) | 2.80763570 |
| 101 | cellular sodium ion homeostasis (GO:0006883) | 2.78943952 |
| 102 | cell communication by electrical coupling (GO:0010644) | 2.76912678 |
| 103 | extracellular matrix assembly (GO:0085029) | 2.75078511 |
| 104 | regulation of triglyceride catabolic process (GO:0010896) | 2.74313442 |
| 105 | response to growth hormone (GO:0060416) | 2.73593768 |
| 106 | myelination in peripheral nervous system (GO:0022011) | 2.73480546 |
| 107 | peripheral nervous system axon ensheathment (GO:0032292) | 2.73480546 |
| 108 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.72621410 |
| 109 | regulation of p38MAPK cascade (GO:1900744) | 2.72259286 |
| 110 | serine family amino acid metabolic process (GO:0009069) | 2.70161617 |
| 111 | hormone catabolic process (GO:0042447) | 2.69457891 |
| 112 | barbed-end actin filament capping (GO:0051016) | 2.68378282 |
| 113 | regulation of protein activation cascade (GO:2000257) | 2.67747624 |
| 114 | regulation of complement activation (GO:0030449) | 2.65821436 |
| 115 | aromatic amino acid family metabolic process (GO:0009072) | 2.65759088 |
| 116 | endothelial cell morphogenesis (GO:0001886) | 2.65059509 |
| 117 | neuronal ion channel clustering (GO:0045161) | 2.64674537 |
| 118 | phospholipid homeostasis (GO:0055091) | 2.64457561 |
| 119 | myofibril assembly (GO:0030239) | 2.63315380 |
| 120 | extracellular fibril organization (GO:0043206) | 2.62931311 |
| 121 | cell migration involved in heart development (GO:0060973) | 2.62479775 |
| 122 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.62148786 |
| 123 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.61720890 |
| 124 | cardiac myofibril assembly (GO:0055003) | 2.59943308 |
| 125 | positive regulation of receptor recycling (GO:0001921) | 2.57801084 |
| 126 | activation of protein kinase A activity (GO:0034199) | 2.55669909 |
| 127 | astrocyte development (GO:0014002) | 2.55217581 |
| 128 | virion attachment to host cell (GO:0019062) | 2.53639787 |
| 129 | adhesion of symbiont to host cell (GO:0044650) | 2.53639787 |
| 130 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.51802023 |
| 131 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.51769964 |
| 132 | response to epinephrine (GO:0071871) | 2.50483898 |
| 133 | cell communication involved in cardiac conduction (GO:0086065) | 2.50380090 |
| 134 | regulation of actin filament-based movement (GO:1903115) | 2.47295366 |
| 135 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.46569222 |
| 136 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.45469990 |
| 137 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.44735573 |
| 138 | cardiac muscle contraction (GO:0060048) | 2.41657537 |
| 139 | cAMP biosynthetic process (GO:0006171) | 2.41245840 |
| 140 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.40414510 |
| 141 | glomerular basement membrane development (GO:0032836) | 2.39550925 |
| 142 | endothelium development (GO:0003158) | 2.38876005 |
| 143 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.37568661 |
| 144 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.36952979 |
| 145 | fibril organization (GO:0097435) | 2.33993961 |
| 146 | sodium ion homeostasis (GO:0055078) | 2.31009123 |
| 147 | actin filament depolymerization (GO:0030042) | 2.29596344 |
| 148 | triglyceride catabolic process (GO:0019433) | 2.29211508 |
| 149 | cellular response to monoamine stimulus (GO:0071868) | 2.27503709 |
| 150 | cellular response to catecholamine stimulus (GO:0071870) | 2.27503709 |
| 151 | negative regulation of complement activation (GO:0045916) | 2.26443955 |
| 152 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.25228252 |
| 153 | striated muscle hypertrophy (GO:0014897) | 2.24457627 |
| 154 | * renal absorption (GO:0070293) | 2.24014936 |
| 155 | response to dietary excess (GO:0002021) | 2.22695542 |
| 156 | actin filament capping (GO:0051693) | 2.22365773 |
| 157 | atrioventricular valve morphogenesis (GO:0003181) | 2.21640046 |
| 158 | adhesion of symbiont to host (GO:0044406) | 2.21040206 |
| 159 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.20257559 |
| 160 | potassium ion homeostasis (GO:0055075) | 2.17471706 |
| 161 | regulation of the force of heart contraction (GO:0002026) | 2.17254629 |
| 162 | complement activation, classical pathway (GO:0006958) | 2.15811891 |
| 163 | potassium ion import (GO:0010107) | 2.15418352 |
| 164 | creatine metabolic process (GO:0006600) | 2.15369100 |
| 165 | neuron projection regeneration (GO:0031102) | 2.14968309 |
| 166 | positive regulation of p38MAPK cascade (GO:1900745) | 2.14677956 |
| 167 | muscle filament sliding (GO:0030049) | 2.13732648 |
| 168 | actin-myosin filament sliding (GO:0033275) | 2.13732648 |
| 169 | endothelial cell chemotaxis (GO:0035767) | 2.13030973 |
| 170 | negative regulation of protein localization to cell surface (GO:2000009) | 2.11956382 |
| 171 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.10462533 |
| 172 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.10063050 |
| 173 | * cell volume homeostasis (GO:0006884) | 2.09916043 |
| 174 | acylglycerol catabolic process (GO:0046464) | 2.09371824 |
| 175 | neutral lipid catabolic process (GO:0046461) | 2.09371824 |
| 176 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.08814416 |
| 177 | complement activation (GO:0006956) | 2.08336006 |
| 178 | muscle hypertrophy (GO:0014896) | 2.07762733 |
| 179 | myelin maintenance (GO:0043217) | 2.07125587 |
| 180 | import into cell (GO:0098657) | 2.06969704 |
| 181 | positive regulation of glucose import (GO:0046326) | 2.06545059 |
| 182 | response to monoamine (GO:0071867) | 2.06256016 |
| 183 | response to catecholamine (GO:0071869) | 2.06256016 |
| 184 | venous blood vessel morphogenesis (GO:0048845) | 2.06170948 |
| 185 | regulation of extracellular matrix disassembly (GO:0010715) | 2.05952003 |
| 186 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.05146900 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.44091263 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.52393135 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.76267080 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.18818567 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.93037234 |
| 6 | * CLOCK_20551151_ChIP-Seq_293T_Human | 3.40826879 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.31403982 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.12945218 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.00888772 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.92896495 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.87442095 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.85538772 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.68064920 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.38202143 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.28211825 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.18959728 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.16602794 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.11944427 |
| 19 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.04734206 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96557396 |
| 21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.89728802 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88534570 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.85581768 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.84438675 |
| 25 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.81729362 |
| 26 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.81729362 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.81005575 |
| 28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.72952084 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.71163608 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.70314702 |
| 31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.70314702 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.70074577 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.68070561 |
| 34 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.66846658 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.66578091 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66147744 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.64116333 |
| 38 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.62679729 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60629291 |
| 40 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.60079700 |
| 41 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.58545981 |
| 42 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.54103430 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52438926 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.49093017 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.47814306 |
| 46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.46375106 |
| 47 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.45429517 |
| 48 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.45342814 |
| 49 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.44402511 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.42637306 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.42511722 |
| 52 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.39849532 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39329052 |
| 54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38741280 |
| 55 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.37466066 |
| 56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35309427 |
| 57 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.33601888 |
| 58 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.32048566 |
| 59 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.31847492 |
| 60 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.31603295 |
| 61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30829301 |
| 62 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.30716090 |
| 63 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29158485 |
| 64 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27331357 |
| 65 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.27011462 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25975978 |
| 67 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24616366 |
| 68 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.24391417 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22591727 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21723104 |
| 71 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.20997119 |
| 72 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.20305018 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19805132 |
| 74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19398384 |
| 75 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.19318269 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17836014 |
| 77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17627142 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16460810 |
| 79 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.13738278 |
| 80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13009991 |
| 81 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12261554 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12169074 |
| 83 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10985473 |
| 84 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.10208083 |
| 85 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09201677 |
| 86 | CJUN_26792858_Chip-Seq_BT549_Human | 1.08608317 |
| 87 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.08327440 |
| 88 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05746978 |
| 89 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.05041415 |
| 90 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03864227 |
| 91 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03767302 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03685691 |
| 93 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03596822 |
| 94 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01011771 |
| 95 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.00655688 |
| 96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99663300 |
| 97 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98877754 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98521852 |
| 99 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97500278 |
| 100 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96667180 |
| 101 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96466049 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95655993 |
| 103 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93832560 |
| 104 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93209369 |
| 105 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92008360 |
| 106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91026612 |
| 107 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.90809332 |
| 108 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90149551 |
| 109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88861195 |
| 110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88313134 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87520788 |
| 112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87299520 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86928509 |
| 114 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.86628639 |
| 115 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86562406 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86219238 |
| 117 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.84350452 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83585694 |
| 119 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.83475718 |
| 120 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.83439869 |
| 121 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.82086279 |
| 122 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.80397711 |
| 123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80353384 |
| 124 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.80125235 |
| 125 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80064729 |
| 126 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.79985486 |
| 127 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79882940 |
| 128 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79814134 |
| 129 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.79190904 |
| 130 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79060073 |
| 131 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78549323 |
| 132 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.78414892 |
| 133 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.78039223 |
| 134 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.77627547 |
| 135 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.77492249 |
| 136 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.77408089 |
| 137 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77049234 |
| 138 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.76618954 |
| 139 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.76576513 |
| 140 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74999360 |
| 141 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74662623 |
| 142 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.73994770 |
| 143 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.73657280 |
| 144 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.73587131 |
| 145 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72854401 |
| 146 | KDM2B_26808549_Chip-Seq_K562_Human | 0.72261336 |
| 147 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72185659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.16651520 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.18962616 |
| 3 | MP0010368_abnormal_lymphatic_system | 3.14432220 |
| 4 | MP0005503_abnormal_tendon_morphology | 2.98796910 |
| 5 | MP0003690_abnormal_glial_cell | 2.86891048 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 2.77793175 |
| 7 | MP0003724_increased_susceptibility_to | 2.77390687 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.68502534 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.61900514 |
| 10 | MP0005365_abnormal_bile_salt | 2.61411788 |
| 11 | MP0005332_abnormal_amino_acid | 2.52881969 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.34934494 |
| 13 | MP0001958_emphysema | 2.33022378 |
| 14 | MP0000751_myopathy | 2.28824149 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.21959285 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.21292628 |
| 17 | MP0004272_abnormal_basement_membrane | 2.20984562 |
| 18 | MP0004043_abnormal_pH_regulation | 2.18016459 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 2.17673150 |
| 20 | MP0001879_abnormal_lymphatic_vessel | 2.17196616 |
| 21 | MP0005670_abnormal_white_adipose | 2.16376500 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.15978312 |
| 23 | MP0003252_abnormal_bile_duct | 2.13341469 |
| 24 | MP0004130_abnormal_muscle_cell | 2.12975124 |
| 25 | MP0003195_calcinosis | 2.08846808 |
| 26 | * MP0009643_abnormal_urine_homeostasis | 2.03891509 |
| 27 | MP0004084_abnormal_cardiac_muscle | 2.03662267 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.99395189 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.97949199 |
| 30 | MP0004147_increased_porphyrin_level | 1.96255447 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.96189916 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.85244591 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.79495023 |
| 34 | * MP0001756_abnormal_urination | 1.76415221 |
| 35 | MP0003329_amyloid_beta_deposits | 1.58984087 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.58982631 |
| 37 | MP0005409_darkened_coat_color | 1.58251880 |
| 38 | MP0004036_abnormal_muscle_relaxation | 1.57911751 |
| 39 | MP0005330_cardiomyopathy | 1.57485499 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.51809333 |
| 41 | MP0003646_muscle_fatigue | 1.46936261 |
| 42 | MP0005275_abnormal_skin_tensile | 1.46373914 |
| 43 | MP0000749_muscle_degeneration | 1.42127225 |
| 44 | * MP0004215_abnormal_myocardial_fiber | 1.41502473 |
| 45 | MP0005636_abnormal_mineral_homeostasis | 1.41495133 |
| 46 | MP0001765_abnormal_ion_homeostasis | 1.40682002 |
| 47 | MP0003091_abnormal_cell_migration | 1.40006592 |
| 48 | MP0006054_spinal_hemorrhage | 1.39673533 |
| 49 | MP0002118_abnormal_lipid_homeostasis | 1.36878836 |
| 50 | MP0000750_abnormal_muscle_regeneration | 1.36504842 |
| 51 | MP0000920_abnormal_myelination | 1.34869359 |
| 52 | MP0008775_abnormal_heart_ventricle | 1.34550310 |
| 53 | MP0003075_altered_response_to | 1.34454465 |
| 54 | MP0002136_abnormal_kidney_physiology | 1.34314602 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.33466490 |
| 56 | * MP0002133_abnormal_respiratory_system | 1.32672342 |
| 57 | * MP0005388_respiratory_system_phenotype | 1.32672342 |
| 58 | MP0000609_abnormal_liver_physiology | 1.32145695 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.31921863 |
| 60 | MP0006138_congestive_heart_failure | 1.29692325 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.29674292 |
| 62 | MP0003879_abnormal_hair_cell | 1.28998332 |
| 63 | MP0003828_pulmonary_edema | 1.28987428 |
| 64 | MP0004885_abnormal_endolymph | 1.28477107 |
| 65 | MP0005083_abnormal_biliary_tract | 1.25623419 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 1.24481459 |
| 67 | MP0009115_abnormal_fat_cell | 1.22531554 |
| 68 | MP0000343_altered_response_to | 1.22217685 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.21944918 |
| 70 | MP0005385_cardiovascular_system_phenoty | 1.21282213 |
| 71 | MP0001544_abnormal_cardiovascular_syste | 1.21282213 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19439091 |
| 73 | MP0003186_abnormal_redox_activity | 1.18948282 |
| 74 | MP0004087_abnormal_muscle_fiber | 1.18870724 |
| 75 | MP0003950_abnormal_plasma_membrane | 1.18630048 |
| 76 | MP0005375_adipose_tissue_phenotype | 1.17800874 |
| 77 | MP0005023_abnormal_wound_healing | 1.15860917 |
| 78 | MP0003045_fibrosis | 1.14746633 |
| 79 | MP0008961_abnormal_basal_metabolism | 1.13248198 |
| 80 | MP0003279_aneurysm | 1.13108820 |
| 81 | MP0009840_abnormal_foam_cell | 1.12602717 |
| 82 | MP0001177_atelectasis | 1.11331757 |
| 83 | MP0001666_abnormal_nutrient_absorption | 1.09108132 |
| 84 | MP0005620_abnormal_muscle_contractility | 1.05769666 |
| 85 | MP0005377_hearing/vestibular/ear_phenot | 1.05632038 |
| 86 | MP0003878_abnormal_ear_physiology | 1.05632038 |
| 87 | MP0002972_abnormal_cardiac_muscle | 1.04606898 |
| 88 | MP0001501_abnormal_sleep_pattern | 1.04570029 |
| 89 | MP0000566_synostosis | 1.03841693 |
| 90 | MP0000230_abnormal_systemic_arterial | 1.00103283 |
| 91 | MP0005166_decreased_susceptibility_to | 0.99237696 |
| 92 | MP0000013_abnormal_adipose_tissue | 0.98533147 |
| 93 | MP0002971_abnormal_brown_adipose | 0.98104947 |
| 94 | MP0005165_increased_susceptibility_to | 0.97358933 |
| 95 | MP0005369_muscle_phenotype | 0.96518839 |
| 96 | MP0002933_joint_inflammation | 0.96478404 |
| 97 | MP0010630_abnormal_cardiac_muscle | 0.95896176 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.94372535 |
| 99 | MP0003137_abnormal_impulse_conducting | 0.92835087 |
| 100 | MP0004859_abnormal_synaptic_plasticity | 0.92478374 |
| 101 | MP0004085_abnormal_heartbeat | 0.91105698 |
| 102 | MP0003634_abnormal_glial_cell | 0.90935880 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 0.90268937 |
| 104 | MP0004484_altered_response_of | 0.89447158 |
| 105 | MP0005508_abnormal_skeleton_morphology | 0.88765351 |
| 106 | MP0000747_muscle_weakness | 0.87818516 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.85640059 |
| 108 | MP0004270_analgesia | 0.85112728 |
| 109 | MP0000767_abnormal_smooth_muscle | 0.82396425 |
| 110 | MP0002269_muscular_atrophy | 0.81924921 |
| 111 | MP0002168_other_aberrant_phenotype | 0.80744513 |
| 112 | MP0009764_decreased_sensitivity_to | 0.80170015 |
| 113 | MP0005595_abnormal_vascular_smooth | 0.79389420 |
| 114 | MP0000604_amyloidosis | 0.79066628 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.78923901 |
| 116 | MP0000598_abnormal_liver_morphology | 0.77409395 |
| 117 | MP0002796_impaired_skin_barrier | 0.77237185 |
| 118 | MP0002295_abnormal_pulmonary_circulatio | 0.77161694 |
| 119 | MP0003633_abnormal_nervous_system | 0.76685751 |
| 120 | MP0002128_abnormal_blood_circulation | 0.75763081 |
| 121 | * MP0000249_abnormal_blood_vessel | 0.73740446 |
| 122 | MP0001542_abnormal_bone_strength | 0.72798084 |
| 123 | MP0001851_eye_inflammation | 0.72404076 |
| 124 | MP0001764_abnormal_homeostasis | 0.71740817 |
| 125 | MP0000462_abnormal_digestive_system | 0.71574860 |
| 126 | MP0002896_abnormal_bone_mineralization | 0.70465462 |
| 127 | MP0005164_abnormal_response_to | 0.70278719 |
| 128 | MP0002106_abnormal_muscle_physiology | 0.70242076 |
| 129 | MP0005535_abnormal_body_temperature | 0.68054352 |
| 130 | MP0009278_abnormal_bone_marrow | 0.67319722 |
| 131 | MP0000759_abnormal_skeletal_muscle | 0.66998972 |
| 132 | MP0000003_abnormal_adipose_tissue | 0.65633215 |
| 133 | MP0008004_abnormal_stomach_pH | 0.65386233 |
| 134 | MP0001661_extended_life_span | 0.65184917 |
| 135 | MP0002135_abnormal_kidney_morphology | 0.63859259 |
| 136 | MP0002108_abnormal_muscle_morphology | 0.61174880 |
| 137 | MP0001545_abnormal_hematopoietic_system | 0.61091259 |
| 138 | MP0005397_hematopoietic_system_phenotyp | 0.61091259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 4.59804323 |
| 2 | Gout (HP:0001997) | 4.35893444 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 4.35443498 |
| 4 | Hyperglycinuria (HP:0003108) | 4.12190014 |
| 5 | Interstitial pulmonary disease (HP:0006530) | 3.96778025 |
| 6 | Metabolic alkalosis (HP:0200114) | 3.87720105 |
| 7 | Polycythemia (HP:0001901) | 3.82870545 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 3.75713400 |
| 9 | Abnormality of chloride homeostasis (HP:0011422) | 3.73062592 |
| 10 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.69833845 |
| 11 | Ketoacidosis (HP:0001993) | 3.67360385 |
| 12 | Glomerulonephritis (HP:0000099) | 3.65874314 |
| 13 | Ketosis (HP:0001946) | 3.52291000 |
| 14 | Abnormality of glycine metabolism (HP:0010895) | 3.47742133 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.47742133 |
| 16 | Hyperuricemia (HP:0002149) | 3.47705036 |
| 17 | Increased purine levels (HP:0004368) | 3.47705036 |
| 18 | Abnormality of purine metabolism (HP:0004352) | 3.45837315 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.45041113 |
| 20 | Increased circulating renin level (HP:0000848) | 3.38504856 |
| 21 | Muscle fiber splitting (HP:0003555) | 3.34801938 |
| 22 | Abnormal urine output (HP:0012590) | 3.31194201 |
| 23 | Increased connective tissue (HP:0009025) | 3.31092369 |
| 24 | Deep venous thrombosis (HP:0002625) | 3.23659152 |
| 25 | Abnormality of complement system (HP:0005339) | 3.22165755 |
| 26 | Abnormality of renal excretion (HP:0011036) | 3.15225373 |
| 27 | Hyperammonemia (HP:0001987) | 3.13138359 |
| 28 | Polyuria (HP:0000103) | 3.12121821 |
| 29 | Renal salt wasting (HP:0000127) | 3.11412034 |
| 30 | Hypomagnesemia (HP:0002917) | 3.07561016 |
| 31 | Aortic aneurysm (HP:0004942) | 3.04208569 |
| 32 | Obstructive sleep apnea (HP:0002870) | 2.99687404 |
| 33 | Hyperaldosteronism (HP:0000859) | 2.97277371 |
| 34 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.92489181 |
| 35 | Myoglobinuria (HP:0002913) | 2.92105061 |
| 36 | Proximal tubulopathy (HP:0000114) | 2.91762905 |
| 37 | Alkalosis (HP:0001948) | 2.90093700 |
| 38 | Hypoglycemic coma (HP:0001325) | 2.88294645 |
| 39 | Xanthomatosis (HP:0000991) | 2.87432735 |
| 40 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.77652103 |
| 41 | Aplasia of the phalanges of the hand (HP:0009802) | 2.77652103 |
| 42 | Aplasia involving bones of the extremities (HP:0009825) | 2.77652103 |
| 43 | Distal lower limb muscle weakness (HP:0009053) | 2.75063295 |
| 44 | Generalized aminoaciduria (HP:0002909) | 2.74654620 |
| 45 | Bundle branch block (HP:0011710) | 2.72195318 |
| 46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.70719853 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 2.70719853 |
| 48 | Neurofibrillary tangles (HP:0002185) | 2.65024800 |
| 49 | Nephritis (HP:0000123) | 2.64924336 |
| 50 | Abnormality of magnesium homeostasis (HP:0004921) | 2.59772146 |
| 51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.59529082 |
| 52 | Delayed CNS myelination (HP:0002188) | 2.57253819 |
| 53 | Abnormality of renin-angiotensin system (HP:0000847) | 2.56769808 |
| 54 | Hyporeflexia of lower limbs (HP:0002600) | 2.56235871 |
| 55 | Esophageal varix (HP:0002040) | 2.55776064 |
| 56 | Intrahepatic cholestasis (HP:0001406) | 2.55110252 |
| 57 | Hyperglycinemia (HP:0002154) | 2.54888469 |
| 58 | Vascular tortuosity (HP:0004948) | 2.54740518 |
| 59 | Shallow orbits (HP:0000586) | 2.50855438 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.49746696 |
| 61 | Abnormal atrioventricular conduction (HP:0005150) | 2.44454980 |
| 62 | Spinal rigidity (HP:0003306) | 2.41130897 |
| 63 | Metabolic acidosis (HP:0001942) | 2.40590658 |
| 64 | Lymphangioma (HP:0100764) | 2.40506947 |
| 65 | Atrioventricular block (HP:0001678) | 2.39816930 |
| 66 | Abnormality of proline metabolism (HP:0010907) | 2.38842551 |
| 67 | Hydroxyprolinuria (HP:0003080) | 2.38842551 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.36710473 |
| 69 | Cerebral hemorrhage (HP:0001342) | 2.36430969 |
| 70 | Foot dorsiflexor weakness (HP:0009027) | 2.35898313 |
| 71 | Heart block (HP:0012722) | 2.32391796 |
| 72 | Vascular calcification (HP:0004934) | 2.32333447 |
| 73 | Acanthosis nigricans (HP:0000956) | 2.32212367 |
| 74 | Asymmetric septal hypertrophy (HP:0001670) | 2.31725481 |
| 75 | Hematochezia (HP:0002573) | 2.31424984 |
| 76 | Chondrocalcinosis (HP:0000934) | 2.31370187 |
| 77 | Hypoalphalipoproteinemia (HP:0003233) | 2.31080216 |
| 78 | Arterial tortuosity (HP:0005116) | 2.31048676 |
| 79 | Rhabdomyolysis (HP:0003201) | 2.30600722 |
| 80 | Tetany (HP:0001281) | 2.29146393 |
| 81 | Broad metatarsal (HP:0001783) | 2.28152949 |
| 82 | Abnormal drinking behavior (HP:0030082) | 2.28002733 |
| 83 | Polydipsia (HP:0001959) | 2.28002733 |
| 84 | Abnormality of the foot musculature (HP:0001436) | 2.26231788 |
| 85 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.25700553 |
| 86 | Neck muscle weakness (HP:0000467) | 2.25697976 |
| 87 | Atrial fibrillation (HP:0005110) | 2.25654298 |
| 88 | Difficulty running (HP:0009046) | 2.25203008 |
| 89 | Vomiting (HP:0002013) | 2.24111830 |
| 90 | Exercise-induced myalgia (HP:0003738) | 2.22940537 |
| 91 | Exercise-induced muscle cramps (HP:0003710) | 2.22687357 |
| 92 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.21517673 |
| 93 | Visceral angiomatosis (HP:0100761) | 2.21477117 |
| 94 | Complement deficiency (HP:0004431) | 2.20049493 |
| 95 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.19522931 |
| 96 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.19186090 |
| 97 | Hypoplasia of the iris (HP:0007676) | 2.18692221 |
| 98 | Turricephaly (HP:0000262) | 2.17413997 |
| 99 | Cerebral aneurysm (HP:0004944) | 2.16876988 |
| 100 | Type 1 muscle fiber predominance (HP:0003803) | 2.16404542 |
| 101 | Sudden death (HP:0001699) | 2.14700299 |
| 102 | Joint hemorrhage (HP:0005261) | 2.13756221 |
| 103 | Ventricular tachycardia (HP:0004756) | 2.13392256 |
| 104 | Growth hormone excess (HP:0000845) | 2.12114309 |
| 105 | Action tremor (HP:0002345) | 2.11854771 |
| 106 | Protrusio acetabuli (HP:0003179) | 2.11763145 |
| 107 | Aortic dissection (HP:0002647) | 2.11721281 |
| 108 | Abnormality of Sharpey fibers (HP:0100685) | 2.11576542 |
| 109 | Right ventricular cardiomyopathy (HP:0011663) | 2.11346563 |
| 110 | Potter facies (HP:0002009) | 2.10828965 |
| 111 | Facial shape deformation (HP:0011334) | 2.10828965 |
| 112 | Adrenal overactivity (HP:0002717) | 2.10221732 |
| 113 | EMG: myopathic abnormalities (HP:0003458) | 2.10210222 |
| 114 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.08776262 |
| 115 | Hypokalemia (HP:0002900) | 2.08709244 |
| 116 | Spontaneous hematomas (HP:0007420) | 2.08175318 |
| 117 | Hemorrhage of the eye (HP:0011885) | 2.07165198 |
| 118 | Cavernous hemangioma (HP:0001048) | 2.06856799 |
| 119 | Muscle fiber inclusion bodies (HP:0100299) | 2.04705497 |
| 120 | Hemangiomatosis (HP:0007461) | 2.03939765 |
| 121 | Primary atrial arrhythmia (HP:0001692) | 2.03428291 |
| 122 | Nephrolithiasis (HP:0000787) | 2.02904449 |
| 123 | Nausea (HP:0002018) | 2.02438371 |
| 124 | Increased variability in muscle fiber diameter (HP:0003557) | 2.02160028 |
| 125 | Polar cataract (HP:0010696) | 2.01443481 |
| 126 | Osteolytic defects of the hand bones (HP:0009699) | 2.01109210 |
| 127 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01109210 |
| 128 | Cerebral inclusion bodies (HP:0100314) | 2.00991388 |
| 129 | Distal lower limb amyotrophy (HP:0008944) | 1.99568768 |
| 130 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.99035121 |
| 131 | Axonal loss (HP:0003447) | 1.98252834 |
| 132 | Oligomenorrhea (HP:0000876) | 1.97865893 |
| 133 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.96245527 |
| 134 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.95533243 |
| 135 | Abnormality of the nasal mucosa (HP:0000433) | 1.95479536 |
| 136 | Ventricular arrhythmia (HP:0004308) | 1.95263704 |
| 137 | Hypercortisolism (HP:0001578) | 1.94224369 |
| 138 | Bronchomalacia (HP:0002780) | 1.93276700 |
| 139 | Abnormal cartilage morphology (HP:0002763) | 1.92238157 |
| 140 | Supraventricular arrhythmia (HP:0005115) | 1.91832020 |
| 141 | Supraventricular tachycardia (HP:0004755) | 1.91390435 |
| 142 | Abnormality of potassium homeostasis (HP:0011042) | 1.91084165 |
| 143 | Wormian bones (HP:0002645) | 1.90321947 |
| 144 | Round ear (HP:0100830) | 1.89673468 |
| 145 | Generalized muscle weakness (HP:0003324) | 1.89508453 |
| 146 | Aneurysm (HP:0002617) | 1.89066477 |
| 147 | Nemaline bodies (HP:0003798) | 1.89013977 |
| 148 | Neonatal death (HP:0003811) | 1.87804730 |
| 149 | Lipoatrophy (HP:0100578) | 1.87051895 |
| 150 | Hyperlipoproteinemia (HP:0010980) | 1.86959871 |
| 151 | Glycosuria (HP:0003076) | 1.86114574 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 1.86114574 |
| 153 | Conjunctival hamartoma (HP:0100780) | 1.86089181 |
| 154 | Increased CSF protein (HP:0002922) | 1.85925493 |
| 155 | Malnutrition (HP:0004395) | 1.85250742 |
| 156 | Neonatal onset (HP:0003623) | 1.84430898 |
| 157 | Abnormality of the intrinsic pathway (HP:0010989) | 1.84275234 |
| 158 | Prolonged QT interval (HP:0001657) | 1.83907634 |
| 159 | Pulmonary artery stenosis (HP:0004415) | 1.83791364 |
| 160 | Rapidly progressive (HP:0003678) | 1.82852502 |
| 161 | Amyloidosis (HP:0011034) | 1.82852070 |
| 162 | Syncope (HP:0001279) | 1.82491905 |
| 163 | Alacrima (HP:0000522) | 1.79795151 |
| 164 | Hyperkalemia (HP:0002153) | 1.77535632 |
| 165 | Bladder diverticulum (HP:0000015) | 1.76748498 |
| 166 | Partial duplication of thumb phalanx (HP:0009944) | 1.74875991 |
| 167 | Striae distensae (HP:0001065) | 1.73151212 |
| 168 | Lower limb amyotrophy (HP:0007210) | 1.73027800 |
| 169 | Overgrowth (HP:0001548) | 1.72300393 |
| 170 | Myotonia (HP:0002486) | 1.72155866 |
| 171 | Abnormality of the calf musculature (HP:0001430) | 1.70265712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.50253132 |
| 2 | TRIB3 | 3.39750467 |
| 3 | WNK3 | 3.32286179 |
| 4 | TGFBR2 | 3.22555059 |
| 5 | BCKDK | 3.19812221 |
| 6 | KDR | 3.16650199 |
| 7 | TTN | 3.15526120 |
| 8 | WNK4 | 2.70037034 |
| 9 | RIPK1 | 2.69628818 |
| 10 | ERN1 | 2.39490679 |
| 11 | OXSR1 | 2.20263495 |
| 12 | PKN2 | 2.17107652 |
| 13 | PDK4 | 2.02754222 |
| 14 | PDK3 | 2.02754222 |
| 15 | PRPF4B | 1.89871047 |
| 16 | SIK1 | 1.83416199 |
| 17 | FGFR4 | 1.77885303 |
| 18 | MYLK | 1.75994647 |
| 19 | MAP2K3 | 1.69337385 |
| 20 | MAP3K3 | 1.67125199 |
| 21 | PDK2 | 1.65471360 |
| 22 | MARK1 | 1.63065005 |
| 23 | NTRK3 | 1.59081434 |
| 24 | TGFBR1 | 1.58090669 |
| 25 | EPHB1 | 1.54157889 |
| 26 | OBSCN | 1.41665422 |
| 27 | LRRK2 | 1.41258106 |
| 28 | PTK6 | 1.40192258 |
| 29 | LMTK2 | 1.33422996 |
| 30 | EPHB2 | 1.31103046 |
| 31 | PDGFRA | 1.25772460 |
| 32 | NTRK1 | 1.23816911 |
| 33 | NEK1 | 1.19530926 |
| 34 | TESK1 | 1.16611019 |
| 35 | PTK2B | 1.15317329 |
| 36 | UHMK1 | 1.14882463 |
| 37 | MARK2 | 1.13390715 |
| 38 | CAMK2B | 1.11686520 |
| 39 | CAMK1D | 1.10664000 |
| 40 | ROCK2 | 1.08883271 |
| 41 | MAP3K7 | 1.06520776 |
| 42 | MST1R | 1.05167326 |
| 43 | CDC42BPA | 1.04890704 |
| 44 | MAPK7 | 1.02874141 |
| 45 | PHKG1 | 0.98335210 |
| 46 | PHKG2 | 0.98335210 |
| 47 | FER | 0.96643163 |
| 48 | CAMK2G | 0.93419501 |
| 49 | DAPK2 | 0.93093903 |
| 50 | PRKAA2 | 0.92953944 |
| 51 | DMPK | 0.88076580 |
| 52 | JAK2 | 0.85175920 |
| 53 | PINK1 | 0.85106886 |
| 54 | NTRK2 | 0.83817993 |
| 55 | JAK1 | 0.82978434 |
| 56 | PAK4 | 0.80717852 |
| 57 | MAPKAPK3 | 0.80412224 |
| 58 | LATS1 | 0.79129346 |
| 59 | STK38L | 0.79064871 |
| 60 | NLK | 0.79009059 |
| 61 | KSR2 | 0.78848314 |
| 62 | PRKD1 | 0.78790149 |
| 63 | MAPK12 | 0.78165925 |
| 64 | PRKD3 | 0.75683084 |
| 65 | PKN1 | 0.74115232 |
| 66 | RPS6KA2 | 0.72136525 |
| 67 | MAPK15 | 0.72020952 |
| 68 | GSK3A | 0.72004394 |
| 69 | STK38 | 0.71365723 |
| 70 | CAMK1 | 0.70876779 |
| 71 | PTK2 | 0.70761385 |
| 72 | CAMK2D | 0.70610553 |
| 73 | MAP3K13 | 0.69545327 |
| 74 | PRKAA1 | 0.68456667 |
| 75 | GRK5 | 0.67088023 |
| 76 | STK39 | 0.67004945 |
| 77 | TYRO3 | 0.65722990 |
| 78 | DDR2 | 0.65705142 |
| 79 | CAMK1G | 0.65254062 |
| 80 | SGK1 | 0.64755665 |
| 81 | INSRR | 0.64029096 |
| 82 | NEK9 | 0.63182962 |
| 83 | PDPK1 | 0.62067928 |
| 84 | MET | 0.61499527 |
| 85 | FES | 0.61128348 |
| 86 | PRKCH | 0.59945145 |
| 87 | TRPM7 | 0.59845242 |
| 88 | CSK | 0.59253042 |
| 89 | MOS | 0.59105489 |
| 90 | MAP3K2 | 0.58688460 |
| 91 | MAPK10 | 0.58500898 |
| 92 | PRKG2 | 0.58472142 |
| 93 | NEK6 | 0.57873228 |
| 94 | SGK3 | 0.57827750 |
| 95 | TBK1 | 0.57429894 |
| 96 | TYK2 | 0.57168241 |
| 97 | MAPK11 | 0.56793640 |
| 98 | FLT3 | 0.56120888 |
| 99 | FGFR3 | 0.56025396 |
| 100 | ICK | 0.55853685 |
| 101 | PAK6 | 0.55424506 |
| 102 | HIPK2 | 0.55352238 |
| 103 | FGFR2 | 0.54126421 |
| 104 | PIK3CG | 0.53076493 |
| 105 | MAP3K10 | 0.52885346 |
| 106 | STK10 | 0.52666135 |
| 107 | SGK223 | 0.52623218 |
| 108 | SGK494 | 0.52623218 |
| 109 | PIK3CA | 0.52378309 |
| 110 | MAP3K11 | 0.52076835 |
| 111 | ERBB2 | 0.51797008 |
| 112 | RET | 0.51219147 |
| 113 | CDK5 | 0.51180783 |
| 114 | ILK | 0.50829388 |
| 115 | PRKG1 | 0.49669995 |
| 116 | GRK1 | 0.49381953 |
| 117 | MAP3K6 | 0.47570721 |
| 118 | ABL2 | 0.47139583 |
| 119 | MAP2K1 | 0.46309401 |
| 120 | WNK1 | 0.43649207 |
| 121 | PAK2 | 0.42272460 |
| 122 | CAMK4 | 0.41632340 |
| 123 | EEF2K | 0.39577342 |
| 124 | MTOR | 0.37151287 |
| 125 | PDGFRB | 0.36340842 |
| 126 | EPHA3 | 0.33598465 |
| 127 | BMX | 0.32614379 |
| 128 | STK3 | 0.32490711 |
| 129 | ROCK1 | 0.31733917 |
| 130 | MAPK4 | 0.31199631 |
| 131 | NME2 | 0.30749954 |
| 132 | SGK2 | 0.30534426 |
| 133 | PRKD2 | 0.30324296 |
| 134 | PRKACG | 0.30266538 |
| 135 | PAK3 | 0.29118600 |
| 136 | MAP3K1 | 0.29069566 |
| 137 | PDK1 | 0.27853603 |
| 138 | LATS2 | 0.27852730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.32392750 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.29153163 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.22004933 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.16901816 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.14062002 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.84179181 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.54851446 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.49243337 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.47910325 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.45740769 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.45631287 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.39149923 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.21064209 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.18115688 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.16495582 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.12666923 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.03321524 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.96415857 |
| 19 | Carbon metabolism_Homo sapiens_hsa01200 | 1.87927326 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84860566 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.82015370 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.77891253 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76978503 |
| 24 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.69170463 |
| 25 | * Bile secretion_Homo sapiens_hsa04976 | 1.57201669 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.54469041 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.47429583 |
| 28 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.42561499 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.40751868 |
| 30 | * Renin secretion_Homo sapiens_hsa04924 | 1.33875628 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.32415981 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.30721476 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29778573 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24397420 |
| 35 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.21686533 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20053041 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.18805549 |
| 38 | Circadian rhythm_Homo sapiens_hsa04710 | 1.18045553 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16987471 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16165279 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11662689 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11303081 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.10787795 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.09135531 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08678277 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08622869 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 1.07494845 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 1.03884390 |
| 49 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.03291080 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 1.02512796 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01296489 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.01189888 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.00844428 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00677729 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99748220 |
| 56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97962578 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97497030 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 0.97007731 |
| 59 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96374838 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96352499 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 0.96030950 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95569598 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94967534 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94961783 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.93139271 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93114527 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88299149 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85450364 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84915346 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84363861 |
| 71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.83897872 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.83347386 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.83127514 |
| 74 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.81567749 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80723216 |
| 76 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.80153845 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.78841887 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77925128 |
| 79 | Cocaine addiction_Homo sapiens_hsa05030 | 0.77352775 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77036038 |
| 81 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74919726 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74488132 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74040356 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73241647 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73198420 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72784819 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72731079 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69602321 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69101889 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67990161 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66473038 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66227666 |
| 93 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.65253694 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65160125 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64859498 |
| 96 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64698500 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.64344968 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63353697 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62606351 |
| 100 | GABAergic synapse_Homo sapiens_hsa04727 | 0.62403185 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59536354 |
| 102 | Morphine addiction_Homo sapiens_hsa05032 | 0.59097299 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58375859 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57074782 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.56912116 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56273771 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55755064 |
| 108 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.55399222 |
| 109 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55075200 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54216880 |
| 111 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54060580 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53796373 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53615528 |
| 114 | Melanogenesis_Homo sapiens_hsa04916 | 0.53340820 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52815311 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52679226 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51865009 |
| 118 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50900153 |
| 119 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49265782 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49201337 |
| 121 | Malaria_Homo sapiens_hsa05144 | 0.48738150 |
| 122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48301788 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48204111 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48176906 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47333889 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45000002 |
| 127 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.38978462 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.37990811 |
| 129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37867335 |
| 130 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37653231 |
| 131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36514836 |
| 132 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35988355 |
| 133 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33441371 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33330712 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32759470 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32132059 |
| 137 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29878728 |
| 138 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28194566 |
| 139 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26831193 |
| 140 | Mineral absorption_Homo sapiens_hsa04978 | 0.25722946 |
| 141 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.23206972 |
| 142 | Adherens junction_Homo sapiens_hsa04520 | 0.23142141 |
| 143 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.20811412 |
| 144 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.20699464 |
| 145 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20356278 |
| 146 | Bladder cancer_Homo sapiens_hsa05219 | 0.16948578 |
| 147 | Tight junction_Homo sapiens_hsa04530 | 0.14259636 |
| 148 | Platelet activation_Homo sapiens_hsa04611 | 0.11890154 |
| 149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10953264 |
| 150 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.10806494 |
| 151 | Alzheimers disease_Homo sapiens_hsa05010 | 0.10763181 |

